Chemicals · Chemicals: Specialty · NSE: ARVEE · data 2026-10-30

Arvee Laboratories (India) Ltd.

₹206.71+5.00% on 30 OctHealth: Weak 3.7/10

Feb 2026Low ₹133.86 · High ₹242.18+25.6%

In plain words

Price: 28.9% below its 52-week high of ₹290.78.

Delivery: 66.0% of traded shares were kept for delivery over the last 10 sessions, against 55.0% over the last 60.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹206.71

Market cap

₹217 cr

P/E

56.2

P/B

—

ROE

7.8%

ROCE

5.7%

Debt / equity

0.03

Dividend yield

0.00%

1-year return

27.6%

52-week high

₹290.78

52-week low

₹129.11

Operating margin

10.0%

Growth

Revenue (last 12 months)	₹41 cr
Net profit (last 12 months)	₹4 cr
Sales growth, 3 years (yearly)	-19.9%
Profit growth, 3 years (yearly)	-15.0%

Smart-money activity

15/100 · Weak over the last ~60 sessions, data 2026-10-30

Delivery vs usual 10/30: Delivery 54.4% over the last 20 sessions vs 30.7% in the 40 before (1.77x); shares delivered per day 0.6x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

● Results

7 Aug 26Results Results board meeting -0.4% next session
19 May 26Results Results board meeting +4.0% next session
13 Feb 26Results Results board meeting +1.5% next session
14 Nov 25Results Results board meeting -0.7% next session
12 Aug 25Results Results board meeting +3.0% next session
9 May 25Results Results board meeting -1.3% next session
12 Feb 25Results Results board meeting -2.5% next session
14 Nov 24Results Results board meeting +1.5% next session

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Common questions

Is Arvee Laboratories (India) Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.03, which is very low.

What is Arvee Laboratories (India) Ltd.'s P/E ratio?

About 56.2, based on the last 12 months' earnings and a price of ₹206.71 (data 2026-10-30).

What is the 52-week high and low of Arvee Laboratories (India) Ltd.?

The 52-week high is ₹290.78 and the 52-week low is ₹129.11.

Similar companies

Dai-Ichi Karkaria Limited (DAICHI) · Ducol Organics & Colours Ltd. (DUCOL) · IVP Ltd (IVP) · Shubhshree Biofuels Energy Ltd. (SHUBHSHREE) · ARCL Organics Ltd. (ARCL)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ARVEE in NSE Scanner →